rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Madhav Vasanthavada

Chief Commercial Officer

Company insider

Files Form 4 as: Chief Commercial Officer, Abeona Therapeutics.

In numbers

Trades disclosed
16
Buys
0
Sells
6
Bought
$0
Sold
$529K
Companies
1
Companies where not an officer
0
First trade
20 Jan 2026
Last trade
29 Sep 2026
Last filed
29 Sep 2026

Companies traded

Where they are an officer
ABEO Abeona TherapeuticsOfficer · Biotechnology · last 29 Sep 20260 buys · 6 sells

Activity over time

1 Jan – 1 Oct
20Jan 26Mar 26Jun 26Aug 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
29 Sep 2026filed 29 Sep 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$25K4,902 at $5.16filing
29 Sep 2026filed 29 Sep 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$25K4,902 at $5.16filing
9 Jul 2026filed 9 Jul 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$88K12,606 at $6.96filing
9 Jul 2026filed 9 Jul 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$88K12,606 at $6.96filing
16 Jun 2026filed 17 Jun 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Code J$1,259222 at $5.67filing
16 Jun 2026filed 17 Jun 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Code J$1,259222 at $5.67filing
9 Jun 2026filed 9 Jun 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$29K5,450 at $5.30filing
9 Jun 2026filed 9 Jun 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$29K5,450 at $5.30filing
8 Jun 2026filed 9 Jun 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$23K4,170 at $5.43filing
8 Jun 2026filed 9 Jun 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$23K4,170 at $5.43filing
11 May 2026filed 11 May 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$33K5,548 at $5.96filing
11 May 2026filed 11 May 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$33K5,548 at $5.96filing
22 Jan 2026filed 26 Jan 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$67K12,610 at $5.29filing
22 Jan 2026filed 26 Jan 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$67K12,610 at $5.29filing
20 Jan 2026filed 26 Jan 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Code A—76,621 at $0.00filing
20 Jan 2026filed 26 Jan 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Code A—76,621 at $0.00filing

News

Abeona Therapeutics (NASDAQ:ABEO) Insider Madhav Vasanthavada Sells 4,902 Shares of Company Stockdailypolitical.com · 30 Sep 2026

1 headline in the last 90 days name Madhav Vasanthavada; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care6

Buys in green, sells in red, by the company’s sector.

Related people

Brendan M. O'MalleySVP, Chief Legal Officer · SVP, Chief Legal Officer at Abeona Therapeutics, filing Form 4 there in the last year
Joseph Walter VazzanoChief Financial Officer · Chief Financial Officer at Abeona Therapeutics, filing Form 4 there in the last year
Vishwas SeshadriChief Executive Officer · Chief Executive Officer at Abeona Therapeutics, filing Form 4 there in the last year
Mark AlvinoDirector · Director at Abeona Therapeutics, filing Form 4 there in the last year
Leila AllandDirector · Director at Abeona Therapeutics, filing Form 4 there in the last year